Correlation of clinicopathological parameters with HGF, c-Met, EGFR, and IGF-1R expression in uveal melanoma

Melanoma Research

Volumn 20, Issue 2, 2010, Pages 126-132

  Topcu Yilmaz, Pinar ^a   Kiratli, Hayyam ^a   Saglam, Arzu ^a   Söylemezoglu, Figen ^a   Hascelik, Gülsen ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

C Met; Epidermal growth factor; Hepatocyte growth factor; Insulin like growth factor 1; Melanoma; Uvea

Indexed keywords

EOSIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HEMATOXYLIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; SOMATOMEDIN C RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENUCLEATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPHOCYTIC INFILTRATION; MALE; MITOSIS; NECROSIS; PIGMENTATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; UVEA MELANOMA;

ADULT; AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MELANOMA; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, IGF TYPE 1; TUMOR MARKERS, BIOLOGICAL; UVEAL NEOPLASMS;

EID: 77949562423     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/CMR.0b013e328335a916     Document Type: Article

References (27)

1. Kivela T, Eskelin S, Kujala E. Metastatic uveal melanoma. Int Ophthalmol Clin 2006; 46:133-149
2. Langley RR, Fidler IJ. Tumor cell-organ microenvironment interactions in the pathogenesis of cancer metastasis. Endocr Rev 2007; 28:297-321
3. Collaborative Ocular Melanoma Study Group. Histopathologic characteristics of uveal melanomas in eyes enucleated from the collaborative ocular melanoma study COMS Report No. 6. Am J Ophthalmol 1998; 125:745-766
4. McLean IW, Foster WD, Zimmerman LE, Gamel JW. Modification of callender's classification of uveal melanoma at the armed forces institute of pathology. Am J Ophthalmol 1983; 96:502-509
5. Diener-West M, Hawkins BS, Markowitz JA, Schachat AP. A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966-1988. Arch Ophthalmol 1992; 110:245-250
6. Abd El All HS, Mishriky AM, Mohamed FA. Epidermal growth factor receptor in colorectal carcinoma: correlation with clinico-pathological prognostic factors. Colorectal Dis 2008; 10:170-178
7. Goldstein NS, Armin M. Epidermal growth factor receptor immunohistochemical reactivity in patients with American Joint Committee on cancer stage IV colon adenocarcinoma: implications for a standardized scoring system. Cancer 2001; 92:1331-1346
8. Chambers AF, Groom AC, MacDonald IC. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2002; 2:563-572
9. Hendrix MJ, Seftor E, Seftor R. Regulation of uveal melanoma interconverted phenotype by HGF/SF. Am J Pathol 1998; 152:855-863
10. Woodward J, Elshaw S, Murray A, Nichols CE, Cross N, Laws D, et al. Stimulation and inhibition of uveal melanoma invasion by HGF, GRO, Il-1a and TGF-b. Invest Ophthalmol Vis Sci 2002; 43:3144-3152
11. Economou MA, All-Ericsson C, Bykov V, Girnita L, Bartolazzi A, Larsson O, et al. Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications. Invest Ophthalmol Vis Sci 2005; 46:4372-4375
12. Mallikarjuna K, Pushparaj V, Biswas J, Krishnakumar S. Expression of epidermal growth factor receptor, ezrin, hepatocyte growth factor, and c-Met in uveal melanoma: an immunohistochemical study. Curr Eye Res 2007; 32:281-290
13. Mendelsohn J. The epidermal growth factor receptor as a target for cancer therapy. Endocr Relat Cancer 2001; 8:3-9
14. Ellis DL, King LE, Nanney LB. Increased EGFR in melanocytic lesions. J Am Acad Dermatol 1992; 27:539-546
15. Ma D, Niederkorn JY. Role of epidermal growth factor receptor in the metastasis of intraocular melanomas. Invest Ophthalmol Vis Sci 1998; 39:1067-1075
16. Hurks HM, Metzelaar-Blok M, Barthen ER, Zwinderman AH, De Wolff-Rouendaal D, Keunen JE, et al. Expression of EGFR: risk factor in uveal melanoma. Invest Ophthalmol Vis Sci 2000; 41:2023-2027
17. Scholes AGM, Hagan S, Hiscott P, Damato BE, Grierson I. Overexpression of epidermal growth factor receptor restricted to macrophages in uveal melanoma. Arch Ophthalmol 2001; 119:373-377
18. All-Ericsson C, Girnita L, Seregard S, Bartolazzi A, Jager MJ, Larsson O. IGF-1 receptor in uveal melanoma: a predictor for metastatic disease and a potential theurapeutic target. Invest Ophthalmol Visual Sci 2002; 43:1-8
19. Mallikarjuna K, Pushparaj V, Biswas J, Krishnakumar S. Expression of insulinlike growth factor receptor (IGF-1R), c-fos and c-jun in uveal melanoma: an immunohistochemical study. Curr Eye Res 2006; 31:875-883
20. Vejchapipat P, Tangkijvanich P, Theamboonlers A, Chongsrisawat V, Chittmittrapap S, Poovorawan Y. Association between serum hepatocyte growth factor and survival in untreated hepatocellular carcinoma. J Gastroenterol 2004; 39:1182-1188
21. Sheen-Chen S, Liu Y, Eng HL, Chou FF. Serum levels of hepatocyte growth factor in patients with breast cancer. Cancer Epidemiol Biomarkers Prev 2005; 14:715-717
22. Toi M, Taniguchi T, Ueno T, Asano M, Funata N, Sekiguchi K, et al. Significance of circulating hepatocyte growth factor level as a prognostic indicator in primary breast cancer. Clin Cancer Res 1998; 4:659-664
23. Gohji K, Nomi M, Niitani Y, Kitazawa S, Fukii A, Katsuoka Y, et al. Independent prognostic value of serum hepatocyte growth factor in bladder cancer. J Clin Oncol 2000; 18:2963-2971
24. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS, Deroo B, et al. Circulating concentrations of insulin-like growth factor-1 and risk of breast cancer. Lancet 1998; 351:1393-1396
25. Giovannucci E, Pollak MN, Platz EA, Willett WC, Stampfer MJ, Majeed N, et al. A prospective study of plasma insulin-like growth factor-1 and binding protein-3 and risk of colorectal neoplasia in women. Cancer Epidemiol Biomarkers Prev 2000; 9:345-349
26. Chan JM, Stamfer MJ, Giovannucci E, Gann PH, Ma J, Wilkinson P, et al. Plasma insulin-like growth factor-1 and prostate cancer risk: a prospective study. Science 1998; 279:563-566
27. Egan KM, Giovanucci E, Gragoudas ES, Pollak M. Role of serum insulin-like growth factor (IGF)-1 in the progression of choroidal melanoma (ARVO abstract). Invest Ophthalmol Vis Sci 2000; 41 (Suppl):S382